Phenotypic and functional analysis of 1,25-dihydroxyvitamin D3 receptor mediated modulation of the human myeloma cell line RPMI 8226.
Several recent studies have demonstrated the presence of specific receptors for the 1,25-dihydroxyvitamin D3 (calcitriol) in activated normal lymphocytes. By DNA cellulose chromatography, we show evidence of such specific receptors in the human myeloma cell line RPMI 8226. Nanomolar concentrations of 1,25-dihydroxyvitamin D3 reduce the proliferation of RPMI 8226 cells significantly and simultaneously induce the appearance of both new properties and phenotype expression, such as butyrate esterase, enhanced expression of CD20 (B1), CD15 (Leu-M1) antigens and lambda chains, and decreased expression of the PC1 antigen using microfluorometric analysis. But such an increased expression of membrane lambda chains was not associated with an enhanced secretion of lambda chains. Furthermore, the bone resorbing activity produced normally by RPMI 8226 cells was reduced significantly after 1,25-dihydroxyvitamin D3 treatment. The possible mechanisms and significance of these new functional and phenotypic properties are discussed with respect to the B-cell lineage.
Rossi
J F
JF
Department of Internal Medicine, Arizona Health Sciences Center, Tucson 85724.
Durie
B G
BG
Duperray
C
C
Braich
T
T
Marion
S L
SL
Pike
J W
JW
Haussler
M R
MR
Janbon
C
C
Bataille
R
R
D001862:Bone Resorption; D002117:Calcitriol / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D006801:Humans; D009101:Multiple Myeloma / Q000032:analysis*; D010641:Phenotype; D018167:Receptors, Calcitriol; D011987:Receptors, Steroid / Q000032:analysis / Q000502:physiology*; D014407:Tumor Cells, Cultured
D018167:Receptors, Calcitriol; D011987:Receptors, Steroid; D003907:Dexamethasone; D002117:Calcitriol